Representatives Chris Collins and Tom Price and other power players have substantial investments in Innate Immunotherapeutics, a company with no approved drugs.
Australian Drug Maker Has Low Profile but Powerful Backers in Washington
The New York Times - 8 Aug 2018 16:46
Representatives Chris Collins and Tom Price and other power players have substantial investments in Innate Immunotherapeutics, a company with no approved drugs.
Share this Article
Recommended